Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Replimune Group Inc (NASDAQ: REPL) closed the day trading at $10.25 up 0.39% from the previous closing price of $10.21. In other words, the price has increased by $0.39 from its previous closing price. On the day, 1.76 million shares were traded. REPL stock price reached its highest trading level at $10.45 during the session, while it also had its lowest trading level at $10.035.
Ratios:
For a better understanding of REPL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.94 and its Current Ratio is at 6.94. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
On October 20, 2025, Wedbush Upgraded its rating to Outperform which previously was Neutral but kept the price unchanged to $18.
Piper Sandler Upgraded its Neutral to Overweight on October 20, 2025, while the target price for the stock was maintained at $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’25 when Hill Emily Luisa sold 9,154 shares for $5.37 per share. The transaction valued at 49,157 led to the insider holds 134,368 shares of the business.
Astley-Sparke Philip sold 32,279 shares of REPL for $260,169 on May 20 ’25. The Director now owns 1,405,071 shares after completing the transaction at $8.06 per share. On May 20 ’25, another insider, Xynos Konstantinos, who serves as the Chief Medical Officer of the company, sold 7,952 shares for $8.06 each. As a result, the insider received 64,093 and left with 146,933 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 800072448 and an Enterprise Value of 473059424.
Stock Price History:
The Beta on a monthly basis for REPL is 0.90, which has changed by -0.13865548 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $17.00, while it has fallen to a 52-week low of $2.68. The 50-Day Moving Average of the stock is 78.65%, while the 200-Day Moving Average is calculated to be 17.66%.
Shares Statistics:
Over the past 3-months, REPL traded about 9.24M shares per day on average, while over the past 10 days, REPL traded about 14507630 shares per day. A total of 77.81M shares are outstanding, with a floating share count of 66.34M. Insiders hold about 15.01% of the company’s shares, while institutions hold 96.64% stake in the company. Shares short for REPL as of 1760486400 were 18250390 with a Short Ratio of 1.98, compared to 1757894400 on 17276245. Therefore, it implies a Short% of Shares Outstanding of 18250390 and a Short% of Float of 43.919998.
Earnings Estimates
Replimune Group Inc (REPL) is currently under the scrutiny of 5.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.7, with high estimates of -$0.6 and low estimates of -$0.82.
Analysts are recommending an EPS of between -$2.76 and -$3.42 for the fiscal current year, implying an average EPS of -$3.0. EPS for the following year is -$1.54, with 4.0 analysts recommending between -$1.04 and -$1.94.
